| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, ISO 9001, USP, BP |
| Suitable for: | Elderly, Adult |
| State: | Powder |
| Purity: | >98% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
|
Product Name
|
Palmitoylethanolamide (PEA) |
CAS
|
544-31-0 |
|
EINECS NO.
|
208-867-9 |
Molecular formula
|
C18H37NO2 |
|
Molecular weight
|
299.50 |
Boiling point
|
461.5 °C |
Palmitoylethanolamide (PEA), an endogenous (manufactured by the body) fatty acid amide, is emerging as a new agent in the treatment of pain and inflammation. As an endogenous agent and one also found in foods such as eggs and milk, no serious side effects or drug-drug interactions been identified.
PEA has been used for many decades in the Netherlands and Europe, but since the 1990s interest in the U.S. has surged. It is classified as a "food for medical purposes" in Europe and as a diet supplement in the U.S.PEA has demonstrated effectiveness for chronic pain of multiple types associated with many painful conditions, especially with neuropathic (nerve) pain, inflammatory pain and visceral pain such as endometriosis and interstitial cystitis.1. Palmitoylethanolamide can reduce various related chronic pain and inflammation.
2. Palmitoylethanolamide can relieve brain inflammation.
3. Palmitoylethanolamide can reduce inflammation and pain.
4. Palmitoylethanolamide can treat epilepsy, cerebral ischemia and stroke health care.
1. Applied in healthcare supplements field
2. Applied in pharmaceutical field
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}